GSK (GLAXF) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    GSK

    OTC: GLAXF · Real-Time Price · USD
    19.77
    -0.58 (-2.85%)
    At close: Sep 05, 2025, 3:50 PM
    20.35
    2.93%
    After-hours: Sep 03, 2025, 08:00 PM EDT

    GSK Income Statement

    Financials in GBP. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 31.38B 30.33B 29.32B 34.11B
    Cost of Revenue
    		 9.05B 8.56B 9.55B 11.6B
    Gross Profit
    		 22.33B 21.76B 19.77B 22.51B
    Operating Income
    		 4.02B 6.75B 6.43B 6.2B
    Interest Income
    		 60M 48M 76M 28M
    Pretax Income
    		 3.48B 6.06B 5.63B 5.44B
    Net Income
    		 2.58B 4.93B 14.96B 4.38B
    Selling & General & Admin
    		 11.02B 9.38B 8.37B 10.97B
    Research & Development
    		 6.4B 6.22B 5.49B 5.28B
    Other Expenses
    		 891M -590M n/a n/a
    Operating Expenses
    		 18.31B 15.02B 13.34B 16.31B
    Interest Expense
    		 640M 775M 879M 784M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 27.36B 23.58B 22.89B 27.91B
    Income Tax Expense
    		 526M 756M 707M 346M
    Shares Outstanding (Basic)
    		 4.08B 4.11B 4.03B 3.2B
    Shares Outstanding (Diluted)
    		 4.14B 4.11B 4.08B 3.24B
    EPS (Basic)
    		 0.63 1.20 3.71 1.37
    EPS (Diluted)
    		 0.62 1.20 3.66 1.35
    EBITDA
    		 6.67B 9.08B 8.6B 6.49B
    EBIT
    		 4.12B 6.79B 6.45B 4.36B
    Depreciation & Amortization
    		 2.55B 2.29B 2.15B 2.12B

    Add to Watchlist